20273 results for «»
20273 results
Tatsuo Takahashi
Tokyo, Japan
Mark Roland de Jong
Hiroyuki Watanabe
Urayasu, Japan
Viviana Mello Guzzo Lemke
Brazil
Makoto Watanabe
Kashihara, Nara, Japan
Switching of oral anticoagulation therapy after PCI in patients with atrial fibrillation: The RE-DUAL PCI trial subanalysis
16 Dec 2019
The objective of this substudy was to examine the safety of switching patients with atrial fibrillation (AF) who were previously on warfarin or a direct oral anticoagulant (DOAC) to dabigatran dual therapy.
Reviewer
Tricuspid Regurgitation (TR) management with the Cardioband Tricuspid System
Georg Nickenig and Axel Linke from Germany describe how the Cardioband can be used to treat tricuspid regurgitation by addressing annular dilation. Watch this video to find out more about how the device is used to reduce the size of the annulus, the most suitable patients...
Early surgery or conservative care for asymptomatic aortic stenosis (RECOVERY)
13 Dec 2019
The RECOVERY trial sought to compare long-term clinical outcomes of early surgical AVR with conservative care strategy according to the current guidelines in asymptomatic patients with very severe AS.
Reviewer
Reviewer
Outcomes of transcatheter aortic valve replacement in mixed aortic valve disease
06 Dec 2019
This study compared the outcomes of TAVR in patients with pure Aortic Stenosis (i.e., without or trivial AR) vs. patients with MAVD (AS associated with mild to moderate or severe AR).
Reviewer
Reviewer
Ali Nazmi Calik
Istanbul, Türkiye
Efficacy and safety of low-dose colchicine after myocardial infarction (COLCOT)
09 Dec 2019
COLCOT was a double-blind RCT, designed to evaluate 0.5 mg oral colchicine daily as compared with placebo in patients within 30 days of acute myocardial infarction.
Reviewer
Reviewer
Arturo Giacaman
Santiago, Chile
Health status after transcatheter vs. surgical aortic valve replacement in low-risk patients with aortic stenosis
05 Dec 2019
Although multiple studies have demonstrated an early health status benefit with TAVI vs. SAVR , this is the first randomized trial to demonstrate a persistent, albeit modest, health status advantage with TAVI at 6 and 12 months—timepoints at which patients are assumed to have recovered fully...
Reviewer
Wishing you all the best since 1989
01 Jan 2020
PCR always has been and always will be a work in progress. We’ve built PCR together and looking back over 30 years of growth and learning, we also look to the future of the PCR community, with confidence and excitement.
Diego Grinfeld
La Plata, Argentina
Sondos Samargandy
Riyadh, Saudi Arabia
Hidetaka Nishina
Tsukuba, Japan
Jungo Kato
Tokyo, Japan
Kazumasa Yamasaki
Sapporo, Japan
Kazuo Shimamura
Osaka, Japan
